Cite
HARVARD Citation
Kavanaugh, A. et al. (n.d.). FRI0448 Secukinumab Provides Sustained Improvements in The Signs and Symptoms of Active Psoriatic Arthritis: 2-Year Efficacy and Safety Results from The Phase 3 Randomised, Double-Blind, Placebo-Controlled Trial, Future 1. Annals of the rheumatic diseases. p. 598. [Online].